Oscar Health (NYSE:OSCR) CFO Sells 18,750 Shares

Key Points

• Oscar Health CFO Richard Scott Blackley sold 18,750 shares at an average price of $31.74, generating $595,125 and reducing his direct holdings by 25% to 56,250 shares.
• OSCR recently traded at $31.31, near its 12-month high of $33.48. The company reported quarterly EPS of $1.10 versus $0.40 expected, while revenue rose 70.4% year over year to $4.88 billion.
• Analysts’ consensus rating remains “Hold”, with an average price target of $26.22, despite some firms upgrading the stock to “strong buy.” Institutional investors own approximately 75.7% of the company.

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) CFO Richard Scott Blackley sold 18,750 shares of the firm's stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $31.74, for a total transaction of $595,125.00. Following the sale, the chief financial officer directly owned 56,250 shares in the company, valued at approximately $1,785,375. The trade was a 25.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Richard Scott Blackley also recently made the following trade(s):

• On Tuesday, June 2nd, Richard Scott Blackley sold 31,683 shares of Oscar Health stock. The shares were sold at an average price of $21.94, for a total transaction of $695,125.02.

Oscar Health Stock Performance

OSCR stock traded down $0.99 on Thursday, hitting $31.31. The company had a trading volume of 6,857,283 shares, compared to its average volume of 7,257,653. Oscar Health, Inc. has a 12-month low of $10.69 and a 12-month high of $33.48. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21. The stock's 50-day simple moving average is $29.91 and its 200 day simple moving average is $21.25. The stock has a market cap of $9.66 billion, a price-to-earnings ratio of 22.36, a P/E/G ratio of 0.64 and a beta of 2.36.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.70. The business had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company's quarterly revenue was up 70.4% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.89) EPS. As a group, equities research analysts expect that Oscar Health, Inc. will post 1.54 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have weighed in on OSCR shares. Wall Street Zen raised Oscar Health from a "buy" rating to a "strong-buy" rating in a report on Sunday, June 14th. Zacks Research raised shares of Oscar Health from a "hold" rating to a "strong-buy" rating in a research report on Monday, July 6th. The Goldman Sachs Group reiterated a "neutral" rating and issued a $30.00 price objective on shares of Oscar Health in a research note on Tuesday, August 11th. Weiss Ratings raised shares of Oscar Health from a "sell (d+)" rating to a "hold (c+)" rating in a report on Tuesday, August 11th. Finally, Wolfe Research started coverage on shares of Oscar Health in a research report on Tuesday, May 5th. They set a "peer perform" rating for the company. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $26.22.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Wellington Management Group LLP raised its stake in Oscar Health by 65.6% during the 2nd quarter. Wellington Management Group LLP now owns 603,675 shares of the company's stock worth $17,217,000 after acquiring an additional 239,109 shares during the period. Public Employees Retirement System of Ohio bought a new position in shares of Oscar Health in the second quarter worth approximately $154,000. Globeflex Capital L P purchased a new stake in shares of Oscar Health in the second quarter worth $178,000. Conway Capital Management Inc. purchased a new stake in shares of Oscar Health in the second quarter worth $214,000. Finally, Wedge Capital Management L L P NC bought a new stake in shares of Oscar Health during the 2nd quarter valued at $32,855,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source